SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 529 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,093,174 | +13.5% | 42,862 | +3.0% | 0.04% | +12.9% |
| Q2 2023 | $8,009,416 | +3309576.0% | 41,616 | +3359.4% | 0.03% | +3000.0% |
| Q1 2023 | $242 | +49.4% | 1,203 | -5.0% | 0.00% | 0.0% |
| Q4 2022 | $162 | -99.9% | 1,266 | +37.3% | 0.00% | 0.0% |
| Q3 2022 | $126,000 | 0.0% | 922 | +29.1% | 0.00% | 0.0% |
| Q2 2022 | $126,000 | -98.1% | 714 | -98.4% | 0.00% | -96.9% |
| Q1 2022 | $6,595,000 | +17.0% | 45,784 | +25.6% | 0.03% | +23.1% |
| Q4 2021 | $5,635,000 | +13.5% | 36,450 | +24.6% | 0.03% | 0.0% |
| Q3 2021 | $4,965,000 | +15415.6% | 29,243 | +13825.2% | 0.03% | – |
| Q2 2021 | $32,000 | -74.6% | 210 | -76.9% | 0.00% | -100.0% |
| Q1 2021 | $126,000 | -13.7% | 911 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $146,000 | – | 834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |